Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women

被引:83
|
作者
Van Servellen, G
Chang, B
Garcia, L
Lombardi, E
机构
[1] Univ Calif Los Angeles, Sch Nursing, Acute Care Sect, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Integrated Subst Abuse Programs, Los Angeles, CA 90095 USA
关键词
D O I
10.1089/10872910260066705
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Antiretroviral treatment nonadherence is complex, implicating more than a patient's ability and motivation to be compliant. The bulk of the research to date focuses on individual level barriers with less emphasis on the many system level factors that potentially impact patients' adherence behaviors. This study examined the effects of system enabling factors in addition to the frequently studied individual predisposing and enabling factors upon nonadherence to treatment. One hundred eighty-two patients from five community-based clinics were interviewed and their medical charts examined. Patients' self-reported nonadherence was correlated with clinicians' assessments of medication and appointment nonadherence. Seven individual predisposing factors (gender, ethnicity, birthplace, years of education, HIV Overview of Problems-Evaluation System [HOPES] psychosocial, Hospital Anxiety and Depression Scale [HADS] anxiety, and HADS depression scores) were found to be significantly associated with treatment adherence/nonadherence. Individual enabling factors (hopefulness and access to health care), as well as treatment by clinic staff, a system enabling factor, were significantly associated with adherence/nonadherence. In a multivariate analysis, six factors-age (younger), gender (female), birth outside the United States, level of hopefulness (lower), access to health care (lower), and treatment by clinic staff (poorer)-accounted for 19.3% of the variance in nonadherence. Results of this study indicated that several individual predisposing and enabling factors were potential predictors of treatment nonadherence; however, system enabling factors, e. g., treatment by clinic staff were also associated with treatment nonadherence. Further studies are needed to examine the complex relationships of individual and system related factors in predicting treatment nonadherence.
引用
收藏
页码:269 / 281
页数:13
相关论文
共 50 条
  • [1] Sexual factors associated with cytomegalovirus seropositivity in human immunodeficiency virus-infected men
    Carre, N
    Robain, M
    Dussaix, E
    SalmonCeron, D
    Meyer, L
    Rouzioux, C
    Bary, M
    Burgard, M
    Dellamonica, P
    Durant, J
    Gallais, H
    Mars, ME
    Gallais, J
    Dormont, J
    Levy, A
    Boue, F
    Lefrere, JJ
    Lerable, J
    Joubert, L
    Cassuto, JP
    Reboulot, B
    Quaranta, M
    Dupont, B
    Beuzelin, C
    Fournier, S
    Vittecoq, D
    Bolliot, C
    Pechalat, MT
    Herson, S
    Coutellier, A
    Gastaut, JA
    Dhiver, C
    Drogoul, MP
    Sereni, D
    Gomez, V
    Bachmeyer, C
    Vilde, JL
    Leport, C
    Colassante, U
    Katlama, C
    Brucker, G
    Sobel, A
    Duval, J
    Majerholc, C
    Deforges, L
    Kazatchkine, M
    Vellay, A
    Buisson, M
    Delfraissy, JF
    Lebras, P
    SEXUALLY TRANSMITTED DISEASES, 1997, 24 (10) : 582 - 586
  • [2] Diagnosis and treatment of androgen deficiency in human immunodeficiency virus-infected men and women
    Mylonakis, E
    Koutkia, P
    Grinspoon, S
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (06) : 857 - 864
  • [3] TESTICULAR DYSFUNCTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MEN
    PORETSKY, L
    CAN, S
    ZUMOFF, B
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (07): : 946 - 953
  • [4] TREATMENT OPTIONS FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PREGNANT-WOMEN
    SPERLING, RS
    STRATTON, P
    OBSTETRICS AND GYNECOLOGY, 1992, 79 (03): : 443 - 448
  • [5] Vaginal infections in human immunodeficiency virus-infected women
    Helfgott, A
    Eriksen, N
    Bundrick, CM
    Lorimor, R
    Van Eckhout, B
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (02) : 347 - 353
  • [6] Vaginal infections in human immunodeficiency virus-infected women
    Oliveira, Paula Matos
    Mascarenhas, Rita Elizabeth
    Ferrer, Suzana Ramos
    Cerqueira Oliveira, Rone Peterson
    Marques Travessa, Iane Erica
    de Castro Gomes, Marques Vinicius
    Rios Grassi, Maria Fernanda
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2008, 30 (03): : 121 - 126
  • [7] Gynecologic infections in human immunodeficiency virus-infected women
    Sobel, JD
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) : 1225 - 1233
  • [8] Human Immunodeficiency Virus Serodiscordance and Dual Contraceptive Method Use Among Human Immunodeficiency Virus-infected Men and Women in Lilongwe, Malawi
    Gausi, Blessings
    Chagomerana, Maganizo B.
    Tang, Jennifer H.
    Hosseinipour, Mina C.
    Haddad, Lisa B.
    Hannock, Tweya
    Phiri, Sam
    SEXUALLY TRANSMITTED DISEASES, 2018, 45 (11) : 747 - 753
  • [9] CLUES TO ENHANCING THE IDENTIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN
    STEIN, MD
    ROSENE, KA
    OBSTETRICS AND GYNECOLOGY, 1992, 80 (02): : 317 - 320